Australia's Imugene extends gains on positive early signs in cancer drug study

Imugene

07/11/2023 02:51

** Shares of Austrlia's Imugene  IMU.AX  rise as much as
20.2% to A$0.063, climbing for the fourth straight day
    ** Stock biggest gainer in the ASX All Ordinaries index
 .AORD 
    ** Co said on Monday it sees positive early signs from its
early-stage study testing the efficacy of cancer-killing virus
VAXINIA
    ** "VAXINIA may be a potent anti-cancer drug"- CEO Leslie
Chong
    ** Stock posts its biggest intraday percentage gain since
June 27, 2022 
    ** Shares hit their highest level since Sept. 19
    ** Nearly 76 mln shares change hands, compared with the
30-day average volume of 24.4 mln
    ** Stock down 64.1% YTD as of last close



 (Reporting by Aaditya Govind Rao in Bengaluru)
 ((Aaditya.govindrao@thomsonreuters.com;))